A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
Clinical trial NCT04978779 · TERMINATED
Trial details
- NCT number
- NCT04978779
- Sponsor
- Vincerx Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2023-05-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.